All Type of News
LG Chem starts to aim for rheumatoid arthritis market
LG Chem will start to aim for the Korean rheumatoid arthritis market.
LG Chem announced on the 28th that the company start to sell a rheumatoid arthritis therapy ‘Eucept(generic name: etanercept)’ in Korea.
Eucept, ...
Indication of All the Substances on every pharmaceutical product distributed in Korea starting this December
This December, all the drugs to be distributed in Korea will be extensively applied by a new rule to indicate all the substances and ingredients.
Moreover, portable oxygen products will be designated as quasi drug fo...
2.7% and 2.1% increases for clinics and dentists, and 3.49% raise for NHIS in 2019
The conversion rates for clinics and dentists got broken down at the recent health care cost negotiation, but they were decided at 2.7% and 2.1% respectively. Thus, the National Health Insurance Service’s increase rat...
Bioequivalent tests will be managed in the same level of control with clinical trials
This October, the process of acquiring approval of bioequivalent test will be dealt the same as the one of acquiring approval of clinical trial.
The Ministry of Food and Drug Safety(MFDS) asked the pharmaceutical ind...
What is the most important factor in recruiting new chairman at KPBMA?
The industry has paid attention to recruiting new Chairman of the Korea Pharmaceutical and Bio-Pharma Manufacturers Association(KPBMA) which has been vacant for a while.
After former Chariman Hee-Mok Won voluntarily ...
Brinks Global signs MOU with DKSH for drug market
Brinks Global, a secured distribution company for pharmaceutical products and valuables, announced the company signed a memorandum of understanding(MOU) for introduction to the drug market and cooperation in secured d...
MFDS extend support from development to commercialization for biologics
The Ministry of Food and Drug Safety(MFDS) announced plans support the entire biologic development and commercialization process.
Food and Drug Safety Ministry Young-Jin Ryu reconfirmed the support policy towards the...
Presidential ‘5th National Bioethics Committee’ starts
The Ministry of Health and Welfare(Minister Neung-Hoo Park) announced they completed forming the 5th National Bioethics Committee, the highest presidential review board for the country’s bioethics and safety policy, a...
‘Inlyta’ applied to national health insurance service this July
‘Inlyta Tab,’ a targeted therapy for renal cancer, will be applied to the national health insurance service this July.
Drug prices of Simponi, a rheumatoid arthritis therapy, and Soliris, a paroxysmal nocturnal hemog...
Last year, amount of medicinal drugs imported and exported reaches to KRW 10 billion
The Korea’s amount of medicinal drugs imported and exported was USD 9.61 billion, close to KRW 10 billion, increased by 11.6% year-on-year.
According to the Korea Health Industry Development Institute’s analysis resu...